# Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis
> Putri K.S.S.

URL kanonis: https://discover.unhas.ac.id/publications/osteoprotegerin-is-an-early-marker-of-the-fibrotic-process-and-of-antifibrotic-t
Jurnal / Konferensi: Lung
Tahun terbit: 2024
DOI: https://doi.org/10.1007/s00408-024-00691-5
ISSN: 03412040
Kuartil SJR: Q1
Citations: 7

## Authors
- Putri K.S.S.

## Abstract
OPG can already be detected during the early stages of fibrosis development and responds, both in early- and late-stage fibrosis, to treatment with antifibrotic drugs currently on the market for lung fibrosis. Therefore, OPG should be further investigated as a potential biomarker for lung fibrosis and a potential surrogate marker for treatment effect.

## Keywords
- Pirfenidone
- Nintedanib
- Medicine
- Osteoprotegerin
- Fibrosis
- Lung
- Pulmonary fibrosis
- Idiopathic pulmonary fibrosis
- Biomarker
- Lung fibrosis
- Bleomycin
- In vivo
- Ex vivo
- Internal medicine
- Pathology
- Biology
- Receptor
- Chemotherapy
- Activator (genetics)
- Biotechnology
- Biochemistry

---
Sumber: Discover Unhas — RIMS Universitas Hasanuddin.
Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.